Efficacy and safety of Glycoprotein IIb/IIIa receptor antagonists in patients with infarct-related cardiogenic shock

dc.affiliation.institute	Medizinische Klinik II	de
dc.contributor.author	Abdin, Amr
dc.contributor.referee	Eitel, Ingo
dc.date.accepted	2018
dc.date.accessioned	2023-08-01T10:22:37Z
dc.date.available	2023-08-01T10:22:37Z
dc.date.issued	2019
dc.identifier.dnbppn	117616046X
dc.identifier.gbvppn	104874454X
dc.identifier.uri	https://epub.uni-luebeck.de/handle/zhb_hl/2239
dc.identifier.urn	urn:nbn:de:gbv:841-20181101354
dc.language	eng
dc.language.iso	en
dc.language.rfc3066	en-US
dc.publisher.department	Sektion Medizin	de
dc.publisher.place	Lübeck	de
dc.subject	Cardiogenic shock	en
dc.subject	Patients	en
dc.subject	Enemies	en
dc.subject	Myocardial infarction	en
dc.subject.ddc	610
dc.title	Efficacy and safety of Glycoprotein IIb/IIIa receptor antagonists in patients with infarct-related cardiogenic shock	en
dc.type	thesis.doctoral

Dateien

Gerade angezeigt 1 - 1 von 1